Peroxisomal translocation of soluble epoxide hydrolase protects against ischemic stroke injury.

Autor: Nelson JW; Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon, USA.; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA., Zhang W; Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon, USA., Alkayed NJ; Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon, USA., Koerner IP; Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Jazyk: angličtina
Zdroj: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2015 Sep; Vol. 35 (9), pp. 1416-20. Date of Electronic Publication: 2015 Jul 01.
DOI: 10.1038/jcbfm.2015.159
Abstrakt: Soluble epoxide hydrolase (sEH) contributes to cardiovascular disease, including stroke, although the exact mechanism remains unclear. While primarily a cytosolic enzyme, sEH can translocate into peroxisomes. The relevance of this for stroke injury is not understood. We tested the hypothesis that sEH-mediated injury is tied to the cytoplasmic localization. We found that a human sEH variant possessing increased affinity to peroxisomes reduced stroke injury in sEH-null mice, whereas infarcts were significantly larger when peroxisomal translocation of sEH was disrupted. We conclude that sEH contributes to stroke injury only when localized in the cytoplasm, while peroxisomal sEH may be protective.
Databáze: MEDLINE